GRI Bio (GRI) Stock Price

GRI Bio Price

NYSE AMEX·CLOSED
1.47USD-0.03 (-2.02 %)
Market closed

The consensus 12-month price target for GRI Bio is 656.88 USD, about 44,585.7% above where the stock trades today. Of 6 analysts, 5 rate the stock a buy — an overall Buy consensus.

GRI Bio stock price

Volume
Details

Stock Price

How to Read This Chart

This chart tracks the historical stock price of GRI Bio over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.

Total Return vs. Price Return

The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.

Intraday Price Data

When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how GRI Bio stock reacts to market openings, earnings releases, or breaking news throughout the trading session.

What to Look For

Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing GRI Bio's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.

GRI Bio Stock Price History
DateGRI Bio Price
7/20/20261.47 USD
7/17/20261.50 USD
7/16/20261.54 USD
7/15/20261.62 USD
7/14/20261.57 USD
7/13/20261.62 USD
7/10/20261.74 USD
7/9/20261.78 USD
7/8/20261.79 USD
7/7/20261.83 USD
7/6/20261.81 USD
7/2/20261.87 USD
7/1/20261.78 USD
6/30/20261.77 USD
6/29/20261.86 USD
6/26/20261.82 USD
6/25/20261.96 USD
6/24/20261.84 USD
6/23/20261.86 USD
6/22/20261.87 USD
6/18/20261.88 USD
6/17/20262.32 USD
6/16/20262.17 USD
6/15/20262.29 USD
6/12/20262.25 USD
6/11/20262.31 USD
6/10/20262.31 USD
6/9/20262.20 USD
6/8/20262.17 USD
6/5/20262.00 USD
6/4/20262.13 USD
6/3/20262.01 USD
6/2/20262.01 USD
6/1/20262.07 USD
5/29/20262.06 USD
5/28/20262.10 USD
5/27/20262.10 USD
5/26/20262.04 USD
5/22/20262.06 USD
5/21/20262.20 USD
5/20/20262.20 USD
5/19/20262.23 USD
5/18/20262.14 USD
5/15/20262.03 USD
5/14/20262.17 USD
5/13/20262.26 USD
5/12/20262.28 USD
5/11/20262.26 USD
5/8/20262.24 USD
5/7/20262.25 USD
5/6/20262.36 USD
5/5/20262.34 USD
5/4/20262.26 USD
5/1/20262.18 USD
4/30/20262.18 USD
4/29/20262.23 USD
4/28/20262.36 USD
4/27/20262.38 USD
4/24/20262.32 USD
4/23/20262.41 USD
4/22/20262.61 USD
4/21/20262.52 USD
4/20/20262.51 USD
4/17/20262.55 USD
4/16/20262.49 USD
4/15/20262.47 USD
4/14/20262.44 USD
4/13/20262.40 USD
4/10/20262.45 USD
4/9/20262.36 USD
4/8/20262.40 USD
4/7/20262.30 USD
4/6/20262.41 USD
4/2/20262.38 USD
4/1/20262.33 USD
3/31/20262.29 USD
3/30/20262.26 USD
3/27/20262.28 USD
3/26/20262.30 USD
3/25/20262.37 USD
3/24/20262.43 USD
3/23/20262.59 USD
3/20/20262.36 USD
3/19/20262.61 USD
3/18/20262.65 USD
3/17/20262.58 USD
3/16/20262.55 USD
3/13/20262.54 USD
3/12/20262.92 USD
3/11/20262.94 USD
3/10/20262.75 USD
3/9/20262.50 USD
3/6/20262.57 USD
3/5/20262.40 USD
3/4/20262.40 USD
3/3/20262.28 USD
3/2/20262.54 USD
2/27/20262.55 USD
2/26/20262.58 USD
2/25/20262.49 USD
2/24/20262.40 USD
2/23/20262.33 USD
2/20/20262.49 USD
2/19/20262.55 USD
2/18/20262.51 USD
2/17/20262.31 USD
2/13/20262.31 USD
2/12/20262.25 USD
2/11/20262.39 USD
2/10/20262.39 USD
2/9/20262.45 USD
2/6/20262.39 USD
2/5/20262.19 USD
2/4/20262.64 USD
2/3/20262.60 USD
2/2/20262.86 USD
1/30/20263.26 USD
1/29/20263.32 USD
1/28/20264.11 USD
1/27/20265.32 USD
1/26/20265.55 USD
1/23/20265.63 USD
1/22/20265.49 USD
1/21/20266.24 USD
1/20/20266.52 USD
1/16/20266.24 USD
1/15/20266.75 USD
1/14/20266.66 USD
1/13/20266.02 USD
1/12/20266.78 USD
1/9/20266.30 USD
1/8/20267.95 USD
1/7/20268.34 USD
1/6/20268.46 USD
1/5/20268.62 USD
1/2/20267.84 USD
12/31/20256.92 USD
12/30/20257.78 USD
12/29/20256.94 USD
12/26/20257.73 USD
12/24/20259.04 USD
12/23/20259.24 USD
12/22/20259.55 USD
12/19/20259.52 USD
12/18/202510.36 USD
12/17/202511.73 USD
12/16/202513.41 USD
12/15/202513.30 USD
12/12/202514.78 USD
12/11/202514.76 USD
12/10/202533.88 USD
12/9/202538.92 USD
12/8/202537.80 USD
12/5/202557.68 USD
12/4/202559.92 USD
12/3/202555.44 USD
12/2/202554.60 USD
12/1/202555.16 USD
11/28/202556.00 USD
11/26/202555.44 USD
11/25/202557.68 USD
11/24/202558.52 USD
11/21/202557.40 USD
11/20/202557.12 USD
11/19/202547.32 USD
11/18/202550.12 USD
11/17/202544.80 USD
11/14/202547.32 USD
11/13/202547.32 USD
11/12/202552.36 USD
11/11/202551.80 USD
11/10/202548.72 USD
11/7/202547.04 USD
11/6/202549.28 USD
11/5/202547.04 USD
11/4/202546.76 USD
11/3/202544.80 USD
10/31/202547.60 USD
10/30/202544.80 USD
10/29/202549.56 USD
10/28/202554.32 USD
10/27/202556.56 USD
10/24/202557.40 USD
10/23/202556.84 USD
10/22/202559.36 USD
10/21/202563.28 USD
10/20/202557.40 USD
10/17/202554.32 USD
10/16/202554.60 USD
10/15/202556.28 USD
10/14/202553.48 USD
10/13/202551.80 USD
10/10/202552.08 USD
10/9/202555.16 USD
10/8/202553.48 USD
10/7/202555.16 USD
10/6/202556.00 USD
10/3/202553.48 USD
10/2/202555.16 USD
10/1/202556.28 USD
9/30/202557.68 USD
9/29/202555.44 USD
9/26/202554.60 USD
9/25/202554.04 USD
9/24/202559.64 USD
9/23/202554.60 USD
9/22/202556.00 USD
9/19/202550.68 USD
9/18/202554.04 USD
9/17/202553.76 USD
9/16/202554.04 USD
9/15/202552.08 USD
9/12/202550.68 USD
9/11/202557.40 USD
9/10/202543.68 USD
9/9/202543.96 USD
9/8/202543.68 USD
9/5/202546.48 USD
9/4/202542.00 USD
9/3/202540.88 USD
9/2/202539.20 USD
8/29/202538.92 USD
8/28/202538.92 USD
8/27/202540.04 USD
8/26/202539.48 USD
8/25/202540.32 USD
8/22/202539.20 USD
8/21/202538.92 USD
8/20/202540.60 USD
8/19/202539.76 USD
8/18/202541.16 USD
8/15/202538.92 USD
8/14/202540.32 USD
8/13/202536.40 USD
8/12/202535.42 USD
8/11/202532.62 USD
8/8/202535.28 USD
8/7/202535.00 USD
8/6/202535.00 USD
8/5/202536.12 USD
8/4/202535.84 USD
8/1/202536.96 USD
7/31/202535.84 USD
7/30/202557.40 USD
7/29/202554.88 USD
7/28/202559.92 USD
7/25/202555.72 USD
7/24/202555.16 USD
7/23/202557.12 USD
Access this data via the Eulerpool API

GRI Bio Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2021
0.00 USD
-9.26 M USD
-9.30 M USD
Jan 1, 2022
0.00 USD
-6.93 M USD
-7.02 M USD
Jan 1, 2023
0.00 USD
-11.39 M USD
-13.04 M USD
Jan 1, 2024
0.00 USD
-8.24 M USD
-10.00 M USD
Jan 1, 2025 (e)
0.00 USD
-12.99 M USD
-1.08 M USD
Jan 1, 2026 (e)
0.00 USD
-12.47 M USD
-320,765.88 USD
Jan 1, 2027 (e)
0.00 USD
-17.57 M USD
-80,880.81 USD
Jan 1, 2028 (e)
0.00 USD
-19.70 M USD
-66,175.21 USD

GRI Bio Income Statement, Balance Sheet, Cash Flow Statement

Last updated Jul 23, 2026, 6:39 AM
 
EBITM USD
NET INCOMEM USD
NET INCOME GROWTH%
SHARESk
20182019202020212022202320242025e2026e2027e2028e
-4.00-3.00-4.00-9.00-6.00-11.00-8.00-12.00-12.00-17.00-19.00
-4.00-3.00-4.00-9.00-7.00-13.00-10.00-1.00
-25.0033.33125.00-22.2285.71-23.08-90.00
6.506.506.506.506.500.106.506.506.506.506.50
Details

Income Statement Key Figures

Revenue and Revenue Growth

Revenue is the starting point of every income statement — it measures the total sales GRI Bio generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.

Gross Margin

Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue GRI Bio retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare GRI Bio's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.

EBIT and EBIT Margin

EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.

Net Income and Earnings Per Share (EPS)

Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.

Shares Outstanding

The total number of shares GRI Bio has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.

Analyst Estimates

The projected figures represent consensus estimates from professional analysts. Compare these forecasts against GRI Bio's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.

GRI Bio stock margins

The GRI Bio margin analysis displays the gross margin, EBIT margin, as well as the profit margin of GRI Bio. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for GRI Bio.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2020
0.00 %
-4,788.00 %
-4,822.00 %
Jan 1, 2021
0.00 %
- %
- %
Jan 1, 2022
0.00 %
- %
- %
Jan 1, 2023
0.00 %
- %
- %
Jan 1, 2024
0.00 %
- %
- %
Jan 1, 2025 (e)
0.00 %
- %
- %
Jan 1, 2026 (e)
0.00 %
- %
- %
Jan 1, 2027 (e)
0.00 %
- %
- %

GRI Bio Stock Revenue, EBIT, Earnings per Share

The GRI Bio earnings per share therefore indicates how much revenue GRI Bio has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue per Share
EBIT per share
Earnings per Share
Details
Date
Revenue per Share
EBIT per share
Earnings per Share
Jan 1, 2020
0.00 USD
0.00 USD
0.00 USD
Jan 1, 2021
0.00 USD
0.00 USD
0.00 USD
Jan 1, 2022
0.00 USD
0.00 USD
0.00 USD
Jan 1, 2023
0.00 USD
-54.20 M USD
-62.06 M USD
Jan 1, 2024
0.00 USD
-603,421.53 USD
-732,307.67 USD
Jan 1, 2025 (e)
0.00 USD
-950,906.30 USD
-79,219.63 USD
Jan 1, 2026 (e)
0.00 USD
-913,444.00 USD
-23,489.93 USD
Jan 1, 2027 (e)
0.00 USD
-1.29 M USD
-5,922.96 USD

GRI Bio business model & stock analysis

GRI Bio Eulerpool Fair Value

Details

Fair Value Estimate

What Is Fair Value?

Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.

Earnings-Based Fair Value

Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.

Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021

Revenue-Based Fair Value

Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"

Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021

Dividend-Based Fair Value

Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.

Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021

How to Use This Chart

When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.

GRI Bio historical P/E ratio, EBIT multiple, and P/S ratio

GRI Bio annual returns

Details

Annual Return

What This Chart Shows

This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.

Price Return

Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.

Dividend Return

Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.

What to Look For

Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.

GRI Bio shares outstanding

The number of shares of GRI Bio was 13.66 in 2025. This indicates how many shares GRI Bio is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Number of stocks
Details
Date
Number of stocks
Jan 1, 2020
6,500.00 Stocks
Jan 1, 2021
6,500.00 Stocks
Jan 1, 2022
6,500.00 Stocks
Jan 1, 2023
0.21 Stocks
Jan 1, 2024
13.66 Stocks
Jan 1, 2025 (e)
13.66 Stocks
Jan 1, 2026 (e)
13.66 Stocks
Jan 1, 2027 (e)
13.66 Stocks

GRI Bio stock splits

In GRI Bio's history, there have been no stock splits.

Current GRI Bio forecasts and price targets in July 2026

Analyst Price Targets 2026
Δ MOM Price Target
2,700.00 %
Buy83.33 % (5)
Hold16.67 % (1)
Sell0.00 % (0)
12M Price Target
656.88
Last Price
1.51
Currency
USD
12M Return Potential
43,401.99 %
LTM Return
0 %

GRI Bio Earnings Estimates

DateEPS estimateRevenue EstimateQuarterly report
8/12/2026-1.21USD0.00USD2026 Q2
5/13/2026-0.91USD0.00USD2026 Q1
11/14/2025-0.94USD0.00USD2025 Q3
8/12/2025-1.32USD0.00USD2025 Q2
11/12/2024-0.74USD0.00USD2024 Q3

GRI Bio shareholder structure

% Name
261.53846%
The Vanguard Group, Inc.
The Vanguard Group, Inc.
237.76923%
UBS Financial Services, Inc.
UBS Financial Services, Inc.
58.98462%
Tower Research Capital LLC
Tower Research Capital LLC
3.83077%
Hertz (Walter Marc)
Hertz (Walter Marc)
3.24615%
BlackRock Institutional Trust Company, N.A.
BlackRock Institutional Trust Company, N.A.
1.80000%
SBI Securities Co., Ltd.
SBI Securities Co., Ltd.

GRI Bio Executives and Management Board

WH

Dr. W. Marc Hertz

(55)

President, Chief Executive Officer, Director · since 2023

Compensation617,224.00 USD
LK

Ms. Leanne Kelly

(48)

Chief Financial Officer

Compensation469,420.00 USD
VC

Dr. Vipin Chaturvedi

(65)

Chief Scientific Officer

Compensation419,420.00 USD
AA

Dr. Albert Agro

(60)

Chief Medical Officer

Compensation406,986.00 USD
DS

Mr. David Szekeres

(51)

Independent Chairman of the Board

Compensation91,000.00 USD

Frequently asked questions about GRI Bio

Analysts currently set an average price target of 656.88 USD for the GRI Bio stock (median: 656.88 USD), implying +43,402.0 % versus the latest price. The consensus is based on 6 analyst ratings.

All fundamentals and in-depth analysis of GRI Bio

Our stock analysis for GRI Bio stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of GRI Bio. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.